<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">34400495</PMID><DateCompleted><Year>2021</Year><Month>08</Month><Day>26</Day></DateCompleted><DateRevised><Year>2024</Year><Month>08</Month><Day>14</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1091-6490</ISSN><JournalIssue CitedMedium="Internet"><Volume>118</Volume><Issue>34</Issue><PubDate><Year>2021</Year><Month>Aug</Month><Day>24</Day></PubDate></JournalIssue><Title>Proceedings of the National Academy of Sciences of the United States of America</Title><ISOAbbreviation>Proc Natl Acad Sci U S A</ISOAbbreviation></Journal><ArticleTitle>Redox imbalance links COVID-19 and myalgic encephalomyelitis/chronic fatigue syndrome.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">e2024358118</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1073/pnas.2024358118</ELocationID><Abstract><AbstractText>Although most patients recover from acute COVID-19, some experience postacute sequelae of severe acute respiratory syndrome coronavirus 2 infection (PASC). One subgroup of PASC is a syndrome called "long COVID-19," reminiscent of myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS). ME/CFS is a debilitating condition, often triggered by viral and bacterial infections, leading to years-long debilitating symptoms including profound fatigue, postexertional malaise, unrefreshing sleep, cognitive deficits, and orthostatic intolerance. Some are skeptical that either ME/CFS or long COVID-19 involves underlying biological abnormalities. However, in this review, we summarize the evidence that people with acute COVID-19 and with ME/CFS have biological abnormalities including redox imbalance, systemic inflammation and neuroinflammation, an impaired ability to generate adenosine triphosphate, and a general hypometabolic state. These phenomena have not yet been well studied in people with long COVID-19, and each of them has been reported in other diseases as well, particularly neurological diseases. We also examine the bidirectional relationship between redox imbalance, inflammation, energy metabolic deficits, and a hypometabolic state. We speculate as to what may be causing these abnormalities. Thus, understanding the molecular underpinnings of both PASC and ME/CFS may lead to the development of novel therapeutics.</AbstractText><CopyrightInformation>Copyright &#xa9; 2021 the Author(s). Published by PNAS.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Paul</LastName><ForeName>Bindu D</ForeName><Initials>BD</Initials><Identifier Source="ORCID">0000-0002-1862-6103</Identifier><AffiliationInfo><Affiliation>Department of Pharmacology and Molecular Sciences, Johns Hopkins University School of Medicine, Baltimore, MD 21205; bpaul8@jhmi.edu ssnyder@jhmi.edu.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, Baltimore, MD 21205.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>The Solomon H. Snyder Department of Neuroscience, Johns Hopkins University School of Medicine, Baltimore, MD 21205.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lemle</LastName><ForeName>Marian D</ForeName><Initials>MD</Initials><Identifier Source="ORCID">0000-0002-2284-2976</Identifier><AffiliationInfo><Affiliation>Solve ME/CFS Initiative, Glendale, CA 91206.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Komaroff</LastName><ForeName>Anthony L</ForeName><Initials>AL</Initials><Identifier Source="ORCID">0000-0001-7672-2518</Identifier><AffiliationInfo><Affiliation>Department of Medicine, Brigham &amp; Women's Hospital, Harvard Medical School, Boston, MA 02120.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Snyder</LastName><ForeName>Solomon H</ForeName><Initials>SH</Initials><Identifier Source="ORCID">0000-0002-6818-7022</Identifier><AffiliationInfo><Affiliation>Department of Pharmacology and Molecular Sciences, Johns Hopkins University School of Medicine, Baltimore, MD 21205; bpaul8@jhmi.edu ssnyder@jhmi.edu.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, Baltimore, MD 21205.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>The Solomon H. Snyder Department of Neuroscience, Johns Hopkins University School of Medicine, Baltimore, MD 21205.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>5U54 AI138370</GrantID><Acronym>NH</Acronym><Agency>NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>DA044123</GrantID><Acronym>NH</Acronym><Agency>NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U54 AI138370</GrantID><Acronym>AI</Acronym><Agency>NIAID NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R21 AG073684</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><Acronym>AHA</Acronym><Agency>American Heart Association-American Stroke Association</Agency><Country>United States</Country></Grant><Grant><GrantID>P50 DA044123</GrantID><Acronym>DA</Acronym><Agency>NIDA NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Proc Natl Acad Sci U S A</MedlineTA><NlmUniqueID>7505876</NlmUniqueID><ISSNLinking>0027-8424</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="N">COVID-19</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004679" MajorTopicYN="N">Encephalomyelitis</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015673" MajorTopicYN="N">Fatigue Syndrome, Chronic</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010084" MajorTopicYN="N">Oxidation-Reduction</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">chronic fatigue syndrome</Keyword><Keyword MajorTopicYN="N">mitochondria</Keyword><Keyword MajorTopicYN="N">myalgic encephalomyelitis</Keyword><Keyword MajorTopicYN="N">redox</Keyword></KeywordList><CoiStatement>The authors declare no competing interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>8</Month><Day>17</Day><Hour>6</Hour><Minute>38</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>8</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>8</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2021</Year><Month>8</Month><Day>16</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34400495</ArticleId><ArticleId IdType="pmc">PMC8403932</ArticleId><ArticleId IdType="doi">10.1073/pnas.2024358118</ArticleId><ArticleId IdType="pii">2024358118</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Al-Aly Z., Xie Y., Bowe B., High-dimensional characterization of post-acute sequalae of COVID-19. Nature 594, 259&#x2013;264 (2021).</Citation><ArticleIdList><ArticleId IdType="pubmed">33887749</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang X., et al. ., Epidemiological, clinical characteristics of cases of SARS-CoV-2 infection with abnormal imaging findings. Int. J. Infect. Dis. 94, 81&#x2013;87 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7270493</ArticleId><ArticleId IdType="pubmed">32205284</ArticleId></ArticleIdList></Reference><Reference><Citation>Disser N. P., et al. ., Musculoskeletal consequences of COVID-19. J. Bone Joint Surg. Am. 102, 1197&#x2013;1204 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7508274</ArticleId><ArticleId IdType="pubmed">32675661</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee M. H., et al. ., Microvascular injury in the brains of patients with COVID-19. N. Engl. J. Med. 384, 481&#x2013;483 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7787217</ArticleId><ArticleId IdType="pubmed">33378608</ArticleId></ArticleIdList></Reference><Reference><Citation>Komaroff A. L., Bateman L., Will COVID-19 lead to myalgic encephalomyelitis/chronic fatigue syndrome? Front. Med. (Lausanne) 7, 606824 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7848220</ArticleId><ArticleId IdType="pubmed">33537329</ArticleId></ArticleIdList></Reference><Reference><Citation>Institute of Medicine , Beyond Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: Redefining an Illness (National Institutes of Health, Washington, DC, 2015).</Citation><ArticleIdList><ArticleId IdType="pubmed">0</ArticleId></ArticleIdList></Reference><Reference><Citation>P&#xe9;rez-Torres I., Manzano-Pech L., Rubio-Ru&#xed;z M. E., Soto M. E., Guarner-Lans V., Nitrosative stress and its association with cardiometabolic disorders. Molecules 25, E2555 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7321091</ArticleId><ArticleId IdType="pubmed">32486343</ArticleId></ArticleIdList></Reference><Reference><Citation>Sies H., Berndt C., Jones D. P., Oxidative stress. Annu. Rev. Biochem. 86, 715&#x2013;748 (2017).</Citation><ArticleIdList><ArticleId IdType="pubmed">28441057</ArticleId></ArticleIdList></Reference><Reference><Citation>Sies H., Jones D. P., Reactive oxygen species (ROS) as pleiotropic physiological signalling agents. Nat. Rev. Mol. Cell Biol. 21, 363&#x2013;383 (2020).</Citation><ArticleIdList><ArticleId IdType="pubmed">32231263</ArticleId></ArticleIdList></Reference><Reference><Citation>Khomich O. A., Kochetkov S. N., Bartosch B., Ivanov A. V., Redox biology of respiratory viral infections. Viruses 10, E392 (2018).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6115776</ArticleId><ArticleId IdType="pubmed">30049972</ArticleId></ArticleIdList></Reference><Reference><Citation>Chernyak B. V., et al. ., COVID-19 and oxidative stress. Biochemistry (Mosc.) 85, 1543&#x2013;1553 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7768996</ArticleId><ArticleId IdType="pubmed">33705292</ArticleId></ArticleIdList></Reference><Reference><Citation>Abouhashem A. S., Singh K., Azzazy H. M. E., Sen C. K., Is low alveolar type II cell SOD3 in the lungs of elderly linked to the observed severity of COVID-19? Antioxid. Redox Signal. 33, 59&#x2013;65 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7307702</ArticleId><ArticleId IdType="pubmed">32323565</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoffmann M., et al. ., SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor. Cell 181, 271&#x2013;280.e8 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7102627</ArticleId><ArticleId IdType="pubmed">32142651</ArticleId></ArticleIdList></Reference><Reference><Citation>Rajagopalan S., et al. ., Angiotensin II-mediated hypertension in the rat increases vascular superoxide production via membrane NADH/NADPH oxidase activation. Contribution to alterations of vasomotor tone. J. Clin. Invest. 97, 1916&#x2013;1923 (1996).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC507261</ArticleId><ArticleId IdType="pubmed">8621776</ArticleId></ArticleIdList></Reference><Reference><Citation>Silvagno F., Vernone A., Pescarmona G. P., The role of glutathione in protecting against the severe inflammatory response triggered by COVID-19. Antioxidants 9, E624 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7402141</ArticleId><ArticleId IdType="pubmed">32708578</ArticleId></ArticleIdList></Reference><Reference><Citation>Hati S., Bhattacharyya S., Impact of thiol-disulfide balance on the binding of COVID-19 spike protein with angiotensin-converting enzyme 2 receptor. ACS Omega 5, 16292&#x2013;16298 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7346263</ArticleId><ArticleId IdType="pubmed">32656452</ArticleId></ArticleIdList></Reference><Reference><Citation>Singh J., Dhindsa R. S., Misra V., Singh B., SARS-CoV2 infectivity is potentially modulated by host redox status. Comput. Struct. Biotechnol. J. 18, 3705&#x2013;3711 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7678423</ArticleId><ArticleId IdType="pubmed">33250972</ArticleId></ArticleIdList></Reference><Reference><Citation>Lan J., et al. ., Structure of the SARS-CoV-2 spike receptor-binding domain bound to the ACE2 receptor. Nature 581, 215&#x2013;220 (2020).</Citation><ArticleIdList><ArticleId IdType="pubmed">32225176</ArticleId></ArticleIdList></Reference><Reference><Citation>Yan R., et al. ., Structural basis for the recognition of SARS-CoV-2 by full-length human ACE2. Science 367, 1444&#x2013;1448 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7164635</ArticleId><ArticleId IdType="pubmed">32132184</ArticleId></ArticleIdList></Reference><Reference><Citation>Jones D. P., Mody V. C. Jr., Carlson J. L., Lynn M. J., Sternberg P. Jr., Redox analysis of human plasma allows separation of pro-oxidant events of aging from decline in antioxidant defenses. Free Radic. Biol. Med. 33, 1290&#x2013;1300 (2002).</Citation><ArticleIdList><ArticleId IdType="pubmed">12398937</ArticleId></ArticleIdList></Reference><Reference><Citation>Giustarini D., Santucci A., Bartolini D., Galli F., Rossi R., The age-dependent decline of the extracellular thiol-disulfide balance and its role in SARS-CoV-2 infection. Redox Biol. 41, 101902 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7889000</ArticleId><ArticleId IdType="pubmed">33662873</ArticleId></ArticleIdList></Reference><Reference><Citation>Fukuda S., et al. ., A potential biomarker for fatigue: Oxidative stress and anti-oxidative activity. Biol. Psychol. 118, 88&#x2013;93 (2016).</Citation><ArticleIdList><ArticleId IdType="pubmed">27224647</ArticleId></ArticleIdList></Reference><Reference><Citation>Miwa K., Fujita M., Fluctuation of serum vitamin E (alpha-tocopherol) concentrations during exacerbation and remission phases in patients with chronic fatigue syndrome. Heart Vessels 25, 319&#x2013;323 (2010).</Citation><ArticleIdList><ArticleId IdType="pubmed">20676841</ArticleId></ArticleIdList></Reference><Reference><Citation>Maes M., Kubera M., Uytterhoeven M., Vrydags N., Bosmans E., Increased plasma peroxides as a marker of oxidative stress in myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS). Med. Sci. Monit. 17, SC11&#x2013;SC15 (2011).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3539515</ArticleId><ArticleId IdType="pubmed">21455120</ArticleId></ArticleIdList></Reference><Reference><Citation>Robinson M., et al. ., Plasma IL-6, its soluble receptors and F2-isoprostanes at rest and during exercise in chronic fatigue syndrome. Scand. J. Med. Sci. Sports 20, 282&#x2013;290 (2010).</Citation><ArticleIdList><ArticleId IdType="pubmed">19422646</ArticleId></ArticleIdList></Reference><Reference><Citation>Manuel y Keenoy B., Moorkens G., Vertommen J., De Leeuw I., Antioxidant status and lipoprotein peroxidation in chronic fatigue syndrome. Life Sci. 68, 2037&#x2013;2049 (2001).</Citation><ArticleIdList><ArticleId IdType="pubmed">11388705</ArticleId></ArticleIdList></Reference><Reference><Citation>Kurup R. K., Kurup P. A., Hypothalamic digoxin, cerebral chemical dominance and myalgic encephalomyelitis. Int. J. Neurosci. 113, 683&#x2013;701 (2003).</Citation><ArticleIdList><ArticleId IdType="pubmed">12745627</ArticleId></ArticleIdList></Reference><Reference><Citation>Smirnova I. V., Pall M. L., Elevated levels of protein carbonyls in sera of chronic fatigue syndrome patients. Mol. Cell. Biochem. 248, 93&#x2013;95 (2003).</Citation><ArticleIdList><ArticleId IdType="pubmed">12870659</ArticleId></ArticleIdList></Reference><Reference><Citation>Jammes Y., Steinberg J. G., Mambrini O., Br&#xe9;geon F., Delliaux S., Chronic fatigue syndrome: Assessment of increased oxidative stress and altered muscle excitability in response to incremental exercise. J. Intern. Med. 257, 299&#x2013;310 (2005).</Citation><ArticleIdList><ArticleId IdType="pubmed">15715687</ArticleId></ArticleIdList></Reference><Reference><Citation>Brkic S., Tomic S., Maric D., Novakov Mikic A., Turkulov V., Lipid peroxidation is elevated in female patients with chronic fatigue syndrome. Med. Sci. Monit. 16, CR628&#x2013;CR632 (2010).</Citation><ArticleIdList><ArticleId IdType="pubmed">21119582</ArticleId></ArticleIdList></Reference><Reference><Citation>Fenouillet E., et al. ., Association of biomarkers with health-related quality of life and history of stressors in myalgic encephalomyelitis/chronic fatigue syndrome patients. J. Transl. Med. 14, 251 (2016).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5006431</ArticleId><ArticleId IdType="pubmed">27580693</ArticleId></ArticleIdList></Reference><Reference><Citation>Jammes Y., Steinberg J. G., Guieu R., Delliaux S., Chronic fatigue syndrome with history of severe infection combined altered blood oxidant status, and reduced potassium efflux and muscle excitability at exercise. Open J. Int. Med. 3, 98&#x2013;105 (2013).</Citation></Reference><Reference><Citation>Shungu D. C., et al. ., Increased ventricular lactate in chronic fatigue syndrome. III. Relationships to cortical glutathione and clinical symptoms implicate oxidative stress in disorder pathophysiology. NMR Biomed. 25, 1073&#x2013;1087 (2012).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3896084</ArticleId><ArticleId IdType="pubmed">22281935</ArticleId></ArticleIdList></Reference><Reference><Citation>Murrough J. W., et al. ., Increased ventricular lactate in chronic fatigue syndrome measured by 1H MRS imaging at 3.0 T. II. Comparison with major depressive disorder. NMR Biomed. 23, 643&#x2013;650 (2010).</Citation><ArticleIdList><ArticleId IdType="pubmed">20661876</ArticleId></ArticleIdList></Reference><Reference><Citation>Mathew S. J., et al. ., Ventricular cerebrospinal fluid lactate is increased in chronic fatigue syndrome compared with generalized anxiety disorder: An in vivo 3.0 T (1)H MRS imaging study. NMR Biomed. 22, 251&#x2013;258 (2009).</Citation><ArticleIdList><ArticleId IdType="pubmed">18942064</ArticleId></ArticleIdList></Reference><Reference><Citation>Su&#xe1;rez A., et al. ., Nitric oxide metabolite production during exercise in chronic fatigue syndrome: A case-control study. J. Womens Health (Larchmt.) 19, 1073&#x2013;1077 (2010).</Citation><ArticleIdList><ArticleId IdType="pubmed">20469961</ArticleId></ArticleIdList></Reference><Reference><Citation>Morris G., Maes M., Oxidative and nitrosative stress and immune-inflammatory pathways in patients with myalgic encephalomyelitis (ME)/chronic fatigue syndrome (CFS). Curr. Neuropharmacol. 12, 168&#x2013;185 (2014).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3964747</ArticleId><ArticleId IdType="pubmed">24669210</ArticleId></ArticleIdList></Reference><Reference><Citation>Morris G., et al. ., Nitrosative stress, hypernitrosylation, and autoimmune responses to nitrosylated proteins: New pathways in neuroprogressive disorders including depression and chronic fatigue syndrome. Mol. Neurobiol. 54, 4271&#x2013;4291 (2017).</Citation><ArticleIdList><ArticleId IdType="pubmed">27339878</ArticleId></ArticleIdList></Reference><Reference><Citation>Maes M., Mihaylova I., Leunis J. C., Chronic fatigue syndrome is accompanied by an IgM-related immune response directed against neopitopes formed by oxidative or nitrosative damage to lipids and proteins. Neuroendocrinol. Lett. 27, 615&#x2013;621 (2006).</Citation><ArticleIdList><ArticleId IdType="pubmed">17159817</ArticleId></ArticleIdList></Reference><Reference><Citation>Nagy-Szakal D., et al. ., Insights into myalgic encephalomyelitis/chronic fatigue syndrome phenotypes through comprehensive metabolomics. Sci. Rep. 8, 10056 (2018).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6030047</ArticleId><ArticleId IdType="pubmed">29968805</ArticleId></ArticleIdList></Reference><Reference><Citation>Naviaux R. K., et al. ., Metabolic features of chronic fatigue syndrome. Proc. Natl. Acad. Sci. U.S.A. 113, E5472&#x2013;E5480 (2016).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5027464</ArticleId><ArticleId IdType="pubmed">27573827</ArticleId></ArticleIdList></Reference><Reference><Citation>Germain A., Ruppert D., Levine S. M., Hanson M. R., Metabolic profiling of a myalgic encephalomyelitis/chronic fatigue syndrome discovery cohort reveals disturbances in fatty acid and lipid metabolism. Mol. Biosyst. 13, 371&#x2013;379 (2017).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5365380</ArticleId><ArticleId IdType="pubmed">28059425</ArticleId></ArticleIdList></Reference><Reference><Citation>Germain A., Ruppert D., Levine S. M., Hanson M. R., Prospective biomarkers from plasma metabolomics of myalgic encephalomyelitis/chronic fatigue syndrome implicate redox imbalance in disease symptomatology. Metabolites 8, E90 (2018).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6315598</ArticleId><ArticleId IdType="pubmed">30563204</ArticleId></ArticleIdList></Reference><Reference><Citation>Sbodio J. I., Snyder S. H., Paul B. D., Redox mechanisms in neurodegeneration: From disease outcomes to therapeutic opportunities. Antioxid. Redox Signal. 30, 1450&#x2013;1499 (2019).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6393771</ArticleId><ArticleId IdType="pubmed">29634350</ArticleId></ArticleIdList></Reference><Reference><Citation>Recalcati S., Invernizzi P., Arosio P., Cairo G., New functions for an iron storage protein: The role of ferritin in immunity and autoimmunity. J. Autoimmun. 30, 84&#x2013;89 (2008).</Citation><ArticleIdList><ArticleId IdType="pubmed">18191543</ArticleId></ArticleIdList></Reference><Reference><Citation>Sedlak T. W., et al. ., Bilirubin and glutathione have complementary antioxidant and cytoprotective roles. Proc. Natl. Acad. Sci. U.S.A. 106, 5171&#x2013;5176 (2009).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2664041</ArticleId><ArticleId IdType="pubmed">19286972</ArticleId></ArticleIdList></Reference><Reference><Citation>Vasavda C., et al. ., Bilirubin links heme metabolism to neuroprotection by scavenging superoxide. Cell Chem. Biol. 26, 1450&#x2013;1460.e7 (2019).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6893848</ArticleId><ArticleId IdType="pubmed">31353321</ArticleId></ArticleIdList></Reference><Reference><Citation>Paul B. D., Snyder S. H., H2S signalling through protein sulfhydration and beyond. Nat. Rev. Mol. Cell Biol. 13, 499&#x2013;507 (2012).</Citation><ArticleIdList><ArticleId IdType="pubmed">22781905</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaye A. D., et al. ., Folic acid supplementation in patients with elevated homocysteine levels. Adv. Ther. 37, 4149&#x2013;4164 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7497502</ArticleId><ArticleId IdType="pubmed">32845472</ArticleId></ArticleIdList></Reference><Reference><Citation>Laforge M., et al. ., Tissue damage from neutrophil-induced oxidative stress in COVID-19. Nat. Rev. Immunol. 20, 515&#x2013;516 (2020). Erratum in: Nat. Rev. Immunol. 20, 579 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7388427</ArticleId><ArticleId IdType="pubmed">32728221</ArticleId></ArticleIdList></Reference><Reference><Citation>Middleton E. A., et al. ., Neutrophil extracellular traps contribute to immunothrombosis in COVID-19 acute respiratory distress syndrome. Blood 136, 1169&#x2013;1179 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7472714</ArticleId><ArticleId IdType="pubmed">32597954</ArticleId></ArticleIdList></Reference><Reference><Citation>Papayannopoulos V., Neutrophil extracellular traps in immunity and disease. Nat. Rev. Immunol. 18, 134&#x2013;147 (2018).</Citation><ArticleIdList><ArticleId IdType="pubmed">28990587</ArticleId></ArticleIdList></Reference><Reference><Citation>Zuo Y., et al. ., Neutrophil extracellular traps in COVID-19. JCI Insight 5, 138999 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7308057</ArticleId><ArticleId IdType="pubmed">32329756</ArticleId></ArticleIdList></Reference><Reference><Citation>Mustafa A. K., Gadalla M. M., Snyder S. H., Signaling by gasotransmitters. Sci. Signal. 2, re2 (2009).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2744355</ArticleId><ArticleId IdType="pubmed">19401594</ArticleId></ArticleIdList></Reference><Reference><Citation>Ignarro L. J., Nitric oxide as a unique signaling molecule in the vascular system: A historical overview. J. Physiol. Pharmacol. 53, 503&#x2013;514 (2002).</Citation><ArticleIdList><ArticleId IdType="pubmed">12512688</ArticleId></ArticleIdList></Reference><Reference><Citation>Ignarro L. J., Physiology and pathophysiology of nitric oxide. Kidney Int. Suppl. 55, S2&#x2013;S5 (1996).</Citation><ArticleIdList><ArticleId IdType="pubmed">8743501</ArticleId></ArticleIdList></Reference><Reference><Citation>Paul B. D., Snyder S. H., Modes of physiologic H2S signaling in the brain and peripheral tissues. Antioxid. Redox Signal. 22, 411&#x2013;423 (2015).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4307159</ArticleId><ArticleId IdType="pubmed">24684551</ArticleId></ArticleIdList></Reference><Reference><Citation>Karki R., et al. ., Synergism of TNF-&#x3b1; and IFN-&#x3b3; triggers inflammatory cell death, tissue damage, and mortality in SARS-CoV-2 infection and cytokine shock syndromes. Cell 184, 149&#x2013;168.e17 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7674074</ArticleId><ArticleId IdType="pubmed">33278357</ArticleId></ArticleIdList></Reference><Reference><Citation>Pall M. L., Levels of nitric oxide synthase product citrulline are elevated in sera of chronic fatigue syndrome patients. J. Chronic Fatigue Syndr. 10, 37&#x2013;41 (2002).</Citation></Reference><Reference><Citation>Filipovic M. R., Zivanovic J., Alvarez B., Banerjee R., Chemical biology of H2S signaling through persulfidation. Chem. Rev. 118, 1253&#x2013;1337 (2018).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6029264</ArticleId><ArticleId IdType="pubmed">29112440</ArticleId></ArticleIdList></Reference><Reference><Citation>Yuan S., Shen X., Kevil C. G., Beyond a gasotransmitter: Hydrogen sulfide and polysulfide in cardiovascular health and immune response. Antioxid. Redox Signal. 27, 634&#x2013;653 (2017).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5576200</ArticleId><ArticleId IdType="pubmed">28398086</ArticleId></ArticleIdList></Reference><Reference><Citation>Mustafa A. K., et al. ., H2S signals through protein S-sulfhydration. Sci. Signal. 2, ra72 (2009).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2998899</ArticleId><ArticleId IdType="pubmed">19903941</ArticleId></ArticleIdList></Reference><Reference><Citation>Zivanovic J., et al. ., Selective persulfide detection reveals evolutionarily conserved antiaging effects of S-sulfhydration. Cell Metab. 30, 1152&#x2013;1170.e13 (2019).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7185476</ArticleId><ArticleId IdType="pubmed">31735592</ArticleId></ArticleIdList></Reference><Reference><Citation>D&#xf3;ka &#xc9;., et al. ., Control of protein function through oxidation and reduction of persulfidated states. Sci. Adv. 6, eaax8358 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6938701</ArticleId><ArticleId IdType="pubmed">31911946</ArticleId></ArticleIdList></Reference><Reference><Citation>Paul B. D., Snyder S. H., Gasotransmitter hydrogen sulfide signaling in neuronal health and disease. Biochem. Pharmacol. 149, 101&#x2013;109 (2018).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5868969</ArticleId><ArticleId IdType="pubmed">29203369</ArticleId></ArticleIdList></Reference><Reference><Citation>Paul B. D., et al. ., Cystathionine &#x3b3;-lyase deficiency mediates neurodegeneration in Huntington&#x2019;s disease. Nature 509, 96&#x2013;100 (2014).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4349202</ArticleId><ArticleId IdType="pubmed">24670645</ArticleId></ArticleIdList></Reference><Reference><Citation>Vandiver M. S., et al. ., Sulfhydration mediates neuroprotective actions of parkin. Nat. Commun. 4, 1626 (2013).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3622945</ArticleId><ArticleId IdType="pubmed">23535647</ArticleId></ArticleIdList></Reference><Reference><Citation>Giovinazzo D., et al. ., Hydrogen sulfide is neuroprotective in Alzheimer&#x2019;s disease by sulfhydrating GSK3&#x3b2; and inhibiting Tau hyperphosphorylation. Proc. Natl. Acad. Sci. U.S.A. 118, e2017225118 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7848711</ArticleId><ArticleId IdType="pubmed">33431651</ArticleId></ArticleIdList></Reference><Reference><Citation>Paul B. D., Neuroprotective roles of the reverse transsulfuration pathway in Alzheimer&#x2019;s disease. Front. Aging Neurosci. 13, 659402 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8007787</ArticleId><ArticleId IdType="pubmed">33796019</ArticleId></ArticleIdList></Reference><Reference><Citation>Renieris G., et al. ., Serum hydrogen sulfide and outcome association in pneumonia by the SARS-CoV-2 coronavirus. Shock 54, 633&#x2013;637 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7363385</ArticleId><ArticleId IdType="pubmed">32433216</ArticleId></ArticleIdList></Reference><Reference><Citation>Miller T. W., et al. ., Hydrogen sulfide is an endogenous potentiator of T cell activation. J. Biol. Chem. 287, 4211&#x2013;4221 (2012).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3281711</ArticleId><ArticleId IdType="pubmed">22167178</ArticleId></ArticleIdList></Reference><Reference><Citation>Dominic P., et al. ., Decreased availability of nitric oxide and hydrogen sulfide is a hallmark of COVID-19. Redox Biol. 43, 101982 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8106525</ArticleId><ArticleId IdType="pubmed">34020311</ArticleId></ArticleIdList></Reference><Reference><Citation>Lemle M. D., Hypothesis: Chronic fatigue syndrome is caused by dysregulation of hydrogen sulfide metabolism. Med. Hypotheses 72, 108&#x2013;109 (2009).</Citation><ArticleIdList><ArticleId IdType="pubmed">18799269</ArticleId></ArticleIdList></Reference><Reference><Citation>Blackstone E., Morrison M., Roth M. B., H2S induces a suspended animation-like state in mice. Science 308, 518 (2005).</Citation><ArticleIdList><ArticleId IdType="pubmed">15845845</ArticleId></ArticleIdList></Reference><Reference><Citation>Cervenka I., Agudelo L. Z., Ruas J. L., Kynurenines: Tryptophan&#x2019;s metabolites in exercise, inflammation, and mental health. Science 357, eaaf9794 (2017).</Citation><ArticleIdList><ArticleId IdType="pubmed">28751584</ArticleId></ArticleIdList></Reference><Reference><Citation>Dr&#xf6;ge W., Breitkreutz R., Glutathione and immune function. Proc. Nutr. Soc. 59, 595&#x2013;600 (2000).</Citation><ArticleIdList><ArticleId IdType="pubmed">11115795</ArticleId></ArticleIdList></Reference><Reference><Citation>Dr&#xf6;ge W., et al. ., Functions of glutathione and glutathione disulfide in immunology and immunopathology. FASEB J. 8, 1131&#x2013;1138 (1994).</Citation><ArticleIdList><ArticleId IdType="pubmed">7958618</ArticleId></ArticleIdList></Reference><Reference><Citation>Jain S. K., Parsanathan R., Achari A. E., Kanikarla-Marie P., Bocchini J. A. Jr., Glutathione stimulates vitamin D regulatory and glucose-metabolism genes, lowers oxidative stress and inflammation, and increases 25-hydroxy-vitamin D levels in blood: A novel approach to treat 25-hydroxyvitamin D deficiency. Antioxid. Redox Signal. 29, 1792&#x2013;1807 (2018).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6208166</ArticleId><ArticleId IdType="pubmed">30160165</ArticleId></ArticleIdList></Reference><Reference><Citation>Jain S. K., Micinski D., Vitamin D upregulates glutamate cysteine ligase and glutathione reductase, and GSH formation, and decreases ROS and MCP-1 and IL-8 secretion in high-glucose exposed U937 monocytes. Biochem. Biophys. Res. Commun. 437, 7&#x2013;11 (2013).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4063448</ArticleId><ArticleId IdType="pubmed">23770363</ArticleId></ArticleIdList></Reference><Reference><Citation>Sbodio J. I., Snyder S. H., Paul B. D., Regulators of the transsulfuration pathway. Br. J. Pharmacol. 176, 583&#x2013;593 (2019).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6346075</ArticleId><ArticleId IdType="pubmed">30007014</ArticleId></ArticleIdList></Reference><Reference><Citation>Mousavi S., Bereswill S., Heimesaat M. M., Immunomodulatory and antimicrobial effects of vitamin C. Eur. J. Microbiol. Immunol. (Bp.) 9, 73&#x2013;79 (2019).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6798581</ArticleId><ArticleId IdType="pubmed">31662885</ArticleId></ArticleIdList></Reference><Reference><Citation>Schneider C., Chemistry and biology of vitamin E. Mol. Nutr. Food Res. 49, 7&#x2013;30 (2005).</Citation><ArticleIdList><ArticleId IdType="pubmed">15580660</ArticleId></ArticleIdList></Reference><Reference><Citation>Filler K., et al. ., Association of mitochondrial dysfunction and fatigue: A review of the literature. BBA Clin. 1, 12&#x2013;23 (2014).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4136529</ArticleId><ArticleId IdType="pubmed">25147756</ArticleId></ArticleIdList></Reference><Reference><Citation>Behan W. M., More I. A., Behan P. O., Mitochondrial abnormalities in the postviral fatigue syndrome. Acta Neuropathol. 83, 61&#x2013;65 (1991).</Citation><ArticleIdList><ArticleId IdType="pubmed">1792865</ArticleId></ArticleIdList></Reference><Reference><Citation>Singh K. K., Chaubey G., Chen J. Y., Suravajhala P., Decoding SARS-CoV-2 hijacking of host mitochondria in COVID-19 pathogenesis. Am. J. Physiol. Cell Physiol. 319, C258&#x2013;C267 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7381712</ArticleId><ArticleId IdType="pubmed">32510973</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu J., et al. ., SARS-CoV-2 ORF9b inhibits RIG-I-MAVS antiviral signaling by interrupting K63-linked ubiquitination of NEMO. Cell Rep. 34, 108761 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7857071</ArticleId><ArticleId IdType="pubmed">33567255</ArticleId></ArticleIdList></Reference><Reference><Citation>Ajaz S., et al. ., Mitochondrial metabolic manipulation by SARS-CoV-2 in peripheral blood mononuclear cells of patients with COVID-19. Am. J. Physiol. Cell Physiol. 320, C57&#x2013;C65 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7816428</ArticleId><ArticleId IdType="pubmed">33151090</ArticleId></ArticleIdList></Reference><Reference><Citation>Codo A. C., et al. ., Elevated glucose levels favor SARS-CoV-2 infection and monocyte response through a HIF-1alpha/glycolysis-dependent axis. Cell Metab. (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7462530</ArticleId><ArticleId IdType="pubmed">32877692</ArticleId></ArticleIdList></Reference><Reference><Citation>Santos C. S., et al. ., Determinants of COVID-19 disease severity in patients with underlying rheumatic disease. Clin. Rheumatol. 39, 2789&#x2013;2796 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7383119</ArticleId><ArticleId IdType="pubmed">32720259</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang D., et al. ., Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China. JAMA 323, 1061&#x2013;1069 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7042881</ArticleId><ArticleId IdType="pubmed">32031570</ArticleId></ArticleIdList></Reference><Reference><Citation>Tomas C., Elson J. L., Newton J. L., Walker M., Substrate utilisation of cultured skeletal muscle cells in patients with CFS. Sci. Rep. 10, 18232 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7588462</ArticleId><ArticleId IdType="pubmed">33106563</ArticleId></ArticleIdList></Reference><Reference><Citation>Tomas C., Elson J. L., Strassheim V., Newton J. L., Walker M., The effect of myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) severity on cellular bioenergetic function. PLoS One 15, e0231136 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7147788</ArticleId><ArticleId IdType="pubmed">32275686</ArticleId></ArticleIdList></Reference><Reference><Citation>Fluge &#xd8;., et al. ., Metabolic profiling indicates impaired pyruvate dehydrogenase function in myalgic encephalopathy/chronic fatigue syndrome. JCI Insight 1, e89376 (2016).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5161229</ArticleId><ArticleId IdType="pubmed">28018972</ArticleId></ArticleIdList></Reference><Reference><Citation>Yamano E., et al. ., Index markers of chronic fatigue syndrome with dysfunction of TCA and urea cycles. Sci. Rep. 6, 34990 (2016).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5057083</ArticleId><ArticleId IdType="pubmed">27725700</ArticleId></ArticleIdList></Reference><Reference><Citation>Billing-Ross P., et al. ., Mitochondrial DNA variants correlate with symptoms in myalgic encephalomyelitis/chronic fatigue syndrome. J. Transl. Med. 14, 19 (2016).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4719218</ArticleId><ArticleId IdType="pubmed">26791940</ArticleId></ArticleIdList></Reference><Reference><Citation>Missailidis D., et al. ., An isolated complex V inefficiency and dysregulated mitochondrial function in immortalized lymphocytes from ME/CFS patients. Int. J. Mol. Sci. 21, E1074 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7036826</ArticleId><ArticleId IdType="pubmed">32041178</ArticleId></ArticleIdList></Reference><Reference><Citation>Sweetman E., et al. ., A SWATH-MS analysis of myalgic encephalomyelitis/chronic fatigue syndrome peripheral blood mononuclear cell proteomes reveals mitochondrial dysfunction. J. Transl. Med. 18, 365 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7512220</ArticleId><ArticleId IdType="pubmed">32972442</ArticleId></ArticleIdList></Reference><Reference><Citation>Mandarano A. H., et al. ., Myalgic encephalomyelitis/chronic fatigue syndrome patients exhibit altered T cell metabolism and cytokine associations. J. Clin. Invest. 130, 1491&#x2013;1505 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7269566</ArticleId><ArticleId IdType="pubmed">31830003</ArticleId></ArticleIdList></Reference><Reference><Citation>Schreiner P., et al. ., Human herpesvirus-6 reactivation, mitochondrial fragmentation, and the coordination of antiviral and metabolic phenotypes in myalgic encephalomyelitis/chronic fatigue syndrome. Immunohorizons 4, 201&#x2013;215 (2020).</Citation><ArticleIdList><ArticleId IdType="pubmed">32327453</ArticleId></ArticleIdList></Reference><Reference><Citation>Snell C. R., Stevens S. R., Davenport T. E., Van Ness J. M., Discriminative validity of metabolic and workload measurements for identifying people with chronic fatigue syndrome. Phys. Ther. 93, 1484&#x2013;1492 (2013).</Citation><ArticleIdList><ArticleId IdType="pubmed">23813081</ArticleId></ArticleIdList></Reference><Reference><Citation>Vermeulen R. C., Vermeulen van Eck I. W., Decreased oxygen extraction during cardiopulmonary exercise test in patients with chronic fatigue syndrome. J. Transl. Med. 12, 20 (2014).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3903040</ArticleId><ArticleId IdType="pubmed">24456560</ArticleId></ArticleIdList></Reference><Reference><Citation>Lien K., et al. ., Abnormal blood lactate accumulation during repeated exercise testing in myalgic encephalomyelitis/chronic fatigue syndrome. Physiol. Rep. 7, e14138 (2019).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6546966</ArticleId><ArticleId IdType="pubmed">31161646</ArticleId></ArticleIdList></Reference><Reference><Citation>Mueller C., Lin J. C., Sheriff S., Maudsley A. A., Younger J. W., Evidence of widespread metabolite abnormalities in myalgic encephalomyelitis/chronic fatigue syndrome: Assessment with whole-brain magnetic resonance spectroscopy. Brain Imaging Behav. 14, 562&#x2013;572 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6612467</ArticleId><ArticleId IdType="pubmed">30617782</ArticleId></ArticleIdList></Reference><Reference><Citation>Fegan K. G., Behan P. O., Bell E. J., Myalgic encephalomyelitis: Report of an epidemic. J. R. Coll. Gen. Pract. 33, 335&#x2013;337 (1983).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1972867</ArticleId><ArticleId IdType="pubmed">6310104</ArticleId></ArticleIdList></Reference><Reference><Citation>Maes M., et al. ., Coenzyme Q10 deficiency in myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) is related to fatigue, autonomic and neurocognitive symptoms and is another risk factor explaining the early mortality in ME/CFS due to cardiovascular disorder. Neuroendocrinol. Lett. 30, 470&#x2013;476 (2009).</Citation><ArticleIdList><ArticleId IdType="pubmed">20010505</ArticleId></ArticleIdList></Reference><Reference><Citation>Maes M., Twisk F. N., Why myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) may kill you: Disorders in the inflammatory and oxidative and nitrosative stress (IO&amp;NS) pathways may explain cardiovascular disorders in ME/CFS. Neuroendocrinol. Lett. 30, 677&#x2013;693 (2009).</Citation><ArticleIdList><ArticleId IdType="pubmed">20038921</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang X., et al. ., Neuroprotection of coenzyme Q10 in neurodegenerative diseases. Curr. Top. Med. Chem. 16, 858&#x2013;866 (2016).</Citation><ArticleIdList><ArticleId IdType="pubmed">26311425</ArticleId></ArticleIdList></Reference><Reference><Citation>Fisicaro P., et al. ., Targeting mitochondrial dysfunction can restore antiviral activity of exhausted HBV-specific CD8 T cells in chronic hepatitis B. Nat. Med. 23, 327&#x2013;336 (2017).</Citation><ArticleIdList><ArticleId IdType="pubmed">28165481</ArticleId></ArticleIdList></Reference><Reference><Citation>Buoncervello M., et al. ., Inflammatory cytokines associated with cancer growth induce mitochondria and cytoskeleton alterations in cardiomyocytes. J. Cell. Physiol. 234, 20453&#x2013;20468 (2019).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6767566</ArticleId><ArticleId IdType="pubmed">30982981</ArticleId></ArticleIdList></Reference><Reference><Citation>Muri J., Kopf M., Redox regulation of immunometabolism. Nat. Rev. Immunol. 21, 363&#x2013;381 (2021).</Citation><ArticleIdList><ArticleId IdType="pubmed">33340021</ArticleId></ArticleIdList></Reference><Reference><Citation>Mittal M., Siddiqui M. R., Tran K., Reddy S. P., Malik A. B., Reactive oxygen species in inflammation and tissue injury. Antioxid. Redox Signal. 20, 1126&#x2013;1167 (2014).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3929010</ArticleId><ArticleId IdType="pubmed">23991888</ArticleId></ArticleIdList></Reference><Reference><Citation>Biswas S. K., Does the interdependence between oxidative stress and inflammation explain the antioxidant paradox? Oxid. Med. Cell. Longev. 2016, 5698931 (2016).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4736408</ArticleId><ArticleId IdType="pubmed">26881031</ArticleId></ArticleIdList></Reference><Reference><Citation>Angelini G., et al. ., Antigen-presenting dendritic cells provide the reducing extracellular microenvironment required for T lymphocyte activation. Proc. Natl. Acad. Sci. U.S.A. 99, 1491&#x2013;1496 (2002).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC122218</ArticleId><ArticleId IdType="pubmed">11792859</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Y., Hu Y., Yu J., Ma T., Retrospective analysis of laboratory testing in 54 patients with severe- or critical-type 2019 novel coronavirus pneumonia. Lab. Invest. 100, 794&#x2013;800 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7184820</ArticleId><ArticleId IdType="pubmed">32341519</ArticleId></ArticleIdList></Reference><Reference><Citation>Hibbs J. B. Jr., et al. ., Evidence for cytokine-inducible nitric oxide synthesis from L-arginine in patients receiving interleukin-2 therapy. J. Clin. Invest. 89, 867&#x2013;877 (1992).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC442932</ArticleId><ArticleId IdType="pubmed">1541678</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsujimoto M., Yokota S., Vilcek J., Weissmann G., Tumor necrosis factor provokes superoxide anion generation from neutrophils. Biochem. Biophys. Res. Commun. 137, 1094&#x2013;1100 (1986).</Citation><ArticleIdList><ArticleId IdType="pubmed">3015137</ArticleId></ArticleIdList></Reference><Reference><Citation>Kharazmi A., Nielsen H., Rechnitzer C., Bendtzen K., Interleukin 6 primes human neutrophil and monocyte oxidative burst response. Immunol. Lett. 21, 177&#x2013;184 (1989).</Citation><ArticleIdList><ArticleId IdType="pubmed">2548955</ArticleId></ArticleIdList></Reference><Reference><Citation>Mehta P.et al. .; HLH Across Specialty Collaboration, UK , COVID-19: Consider cytokine storm syndromes and immunosuppression. Lancet 395, 1033&#x2013;1034 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7270045</ArticleId><ArticleId IdType="pubmed">32192578</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu Z., et al. ., Pathological findings of COVID-19 associated with acute respiratory distress syndrome. Lancet Respir. Med. 8, 420&#x2013;422 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7164771</ArticleId><ArticleId IdType="pubmed">32085846</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao Y., et al. ., Abnormal immunity of non-survivors with COVID-19: Predictors for mortality. Infect. Dis. Poverty 9, 108 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7396941</ArticleId><ArticleId IdType="pubmed">32746940</ArticleId></ArticleIdList></Reference><Reference><Citation>Klug B. J., Brigham R. M., Changes to metabolism and cell physiology that enable mammalian hibernation. Springer Sci. Rev. 3, 39&#x2013;56 (2015).</Citation></Reference><Reference><Citation>Zhang Q.et al. .; COVID-STORM Clinicians; COVID Clinicians; Imagine COVID Group; French COVID Cohort Study Group; CoV-Contact Cohort; Amsterdam UMC Covid-19 Biobank; COVID Human Genetic Effort; NIAID-USUHS/TAGC COVID Immunity Group , Inborn errors of type I IFN immunity in patients with life-threatening COVID-19. Science 370, eabd4570 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7857407</ArticleId><ArticleId IdType="pubmed">32972995</ArticleId></ArticleIdList></Reference><Reference><Citation>Bastard P.et al. .; HGID Lab; NIAID-USUHS Immune Response to COVID Group; COVID Clinicians; COVID-STORM Clinicians; Imagine COVID Group; French COVID Cohort Study Group; Milieu Int&#xe9;rieur Consortium; CoV-Contact Cohort; Amsterdam UMC Covid-19 Biobank; COVID Human Genetic Effort , Autoantibodies against type I IFNs in patients with life-threatening COVID-19. Science 370, eabd4585 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7857397</ArticleId><ArticleId IdType="pubmed">32972996</ArticleId></ArticleIdList></Reference><Reference><Citation>Blanco-Melo D., et al. ., Imbalanced host response to SARS-CoV-2 drives development of COVID-19. Cell 181, 1036&#x2013;1045.e9 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7227586</ArticleId><ArticleId IdType="pubmed">32416070</ArticleId></ArticleIdList></Reference><Reference><Citation>Khanfar A., Al Qaroot B., Could glutathione depletion be the Trojan horse of COVID-19 mortality? Eur. Rev. Med. Pharmacol. Sci. 24, 12500&#x2013;12509 (2020).</Citation><ArticleIdList><ArticleId IdType="pubmed">33336769</ArticleId></ArticleIdList></Reference><Reference><Citation>Natelson B. H., Weaver S. A., Tseng C. L., Ottenweller J. E., Spinal fluid abnormalities in patients with chronic fatigue syndrome. Clin. Diagn. Lab. Immunol. 12, 52&#x2013;55 (2005).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC540195</ArticleId><ArticleId IdType="pubmed">15642984</ArticleId></ArticleIdList></Reference><Reference><Citation>Nakatomi Y., et al. ., Neuroinflammation in patients with chronic fatigue syndrome/myalgic encephalomyelitis: An 11C-(R)-PK11195 PET study. J. Nucl. Med. 55, 945&#x2013;950 (2014).</Citation><ArticleIdList><ArticleId IdType="pubmed">24665088</ArticleId></ArticleIdList></Reference><Reference><Citation>Russell A., et al. ., Persistent fatigue induced by interferon-alpha: A novel, inflammation-based, proxy model of chronic fatigue syndrome. Psychoneuroendocrinology 100, 276&#x2013;285 (2019).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6350004</ArticleId><ArticleId IdType="pubmed">30567628</ArticleId></ArticleIdList></Reference><Reference><Citation>Sweetman E., et al. ., Changes in the transcriptome of circulating immune cells of a New Zealand cohort with myalgic encephalomyelitis/chronic fatigue syndrome. Int. J. Immunopathol. Pharmacol. 33, 2058738418820402 (2019).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6350121</ArticleId><ArticleId IdType="pubmed">30791746</ArticleId></ArticleIdList></Reference><Reference><Citation>Vojdani A., Lapp C. W., Interferon-induced proteins are elevated in blood samples of patients with chemically or virally induced chronic fatigue syndrome. Immunopharmacol. Immunotoxicol. 21, 175&#x2013;202 (1999).</Citation><ArticleIdList><ArticleId IdType="pubmed">10319275</ArticleId></ArticleIdList></Reference><Reference><Citation>Meeus M., et al. ., Unravelling intracellular immune dysfunctions in chronic fatigue syndrome: Interactions between protein kinase R activity, RNase L cleavage and elastase activity, and their clinical relevance. In Vivo 22, 115&#x2013;121 (2008).</Citation><ArticleIdList><ArticleId IdType="pubmed">18396793</ArticleId></ArticleIdList></Reference><Reference><Citation>Bj&#xf8;rklund G., et al. ., Environmental, neuro-immune, and neuro-oxidative stress interactions in chronic fatigue syndrome. Mol. Neurobiol. 57, 4598&#x2013;4607 (2020).</Citation><ArticleIdList><ArticleId IdType="pubmed">32761353</ArticleId></ArticleIdList></Reference><Reference><Citation>Barker E., Fujimura S. F., Fadem M. B., Landay A. L., Levy J. A., Immunologic abnormalities associated with chronic fatigue syndrome. Clin. Infect. Dis. 18 (suppl. 1), S136&#x2013;S141 (1994).</Citation><ArticleIdList><ArticleId IdType="pubmed">8148441</ArticleId></ArticleIdList></Reference><Reference><Citation>Hornig M., et al. ., Distinct plasma immune signatures in ME/CFS are present early in the course of illness. Sci. Adv. 1, e1400121 (2015).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4465185</ArticleId><ArticleId IdType="pubmed">26079000</ArticleId></ArticleIdList></Reference><Reference><Citation>Caligiuri M., et al. ., Phenotypic and functional deficiency of natural killer cells in patients with chronic fatigue syndrome. J. Immunol. 139, 3306&#x2013;3313 (1987).</Citation><ArticleIdList><ArticleId IdType="pubmed">2824604</ArticleId></ArticleIdList></Reference><Reference><Citation>Riggan L., Shah S., O&#x2019;Sullivan T. E., Arrested development: Suppression of NK cell function in the tumor microenvironment. Clin. Transl. Immunology 10, e1238 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7797224</ArticleId><ArticleId IdType="pubmed">33456775</ArticleId></ArticleIdList></Reference><Reference><Citation>Murphy M. P., How mitochondria produce reactive oxygen species. Biochem. J. 417, 1&#x2013;13 (2009).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2605959</ArticleId><ArticleId IdType="pubmed">19061483</ArticleId></ArticleIdList></Reference><Reference><Citation>Abate G., et al. ., Mitochondria and cellular redox state on the route from ageing to Alzheimer&#x2019;s disease. Mech. Ageing Dev. 192, 111385 (2020).</Citation><ArticleIdList><ArticleId IdType="pubmed">33129798</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang R., Mamun A., Dominic A., Le N. T., SARS-CoV-2 mediated endothelial dysfunction: The potential role of chronic oxidative stress. Front. Physiol. 11, 605908 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7844210</ArticleId><ArticleId IdType="pubmed">33519510</ArticleId></ArticleIdList></Reference><Reference><Citation>Saleh J., Peyssonnaux C., Singh K. K., Edeas M., Mitochondria and microbiota dysfunction in COVID-19 pathogenesis. Mitochondrion 54, 1&#x2013;7 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7837003</ArticleId><ArticleId IdType="pubmed">32574708</ArticleId></ArticleIdList></Reference><Reference><Citation>Sadatomi D., et al. ., Mitochondrial function is required for extracellular ATP-induced NLRP3 inflammasome activation. J. Biochem. 161, 503&#x2013;512 (2017).</Citation><ArticleIdList><ArticleId IdType="pubmed">28096454</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou R., Yazdi A. S., Menu P., Tschopp J., A role for mitochondria in NLRP3 inflammasome activation. Nature 469, 221&#x2013;225 (2011).</Citation><ArticleIdList><ArticleId IdType="pubmed">21124315</ArticleId></ArticleIdList></Reference><Reference><Citation>Mills E. L., Kelly B., O&#x2019;Neill L. A. J., Mitochondria are the powerhouses of immunity. Nat. Immunol. 18, 488&#x2013;498 (2017).</Citation><ArticleIdList><ArticleId IdType="pubmed">28418387</ArticleId></ArticleIdList></Reference><Reference><Citation>Paul B. D., Snyder S. H., Bohr V. A., Signaling by cGAS-STING in neurodegeneration, neuroinflammation, and aging. Trends Neurosci. 44, 83&#x2013;96 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8662531</ArticleId><ArticleId IdType="pubmed">33187730</ArticleId></ArticleIdList></Reference><Reference><Citation>Breda C. N. S., Davanzo G. G., Basso P. J., Saraiva C&#xe2;mara N. O., Moraes-Vieira P. M. M., Mitochondria as central hub of the immune system. Redox Biol. 26, 101255 (2019).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6598836</ArticleId><ArticleId IdType="pubmed">31247505</ArticleId></ArticleIdList></Reference><Reference><Citation>Weinberg S. E., Sena L. A., Chandel N. S., Mitochondria in the regulation of innate and adaptive immunity. Immunity 42, 406&#x2013;417 (2015).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4365295</ArticleId><ArticleId IdType="pubmed">25786173</ArticleId></ArticleIdList></Reference><Reference><Citation>Schultze J. L., Aschenbrenner A. C., COVID-19 and the human innate immune system. Cell 184, 1671&#x2013;1692 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7885626</ArticleId><ArticleId IdType="pubmed">33743212</ArticleId></ArticleIdList></Reference><Reference><Citation>Naviaux R. K., Metabolic features and regulation of the healing cycle-A new model for chronic disease pathogenesis and treatment. Mitochondrion 46, 278&#x2013;297 (2019).</Citation><ArticleIdList><ArticleId IdType="pubmed">30099222</ArticleId></ArticleIdList></Reference><Reference><Citation>Costa-Mattioli M., Walter P., The integrated stress response: From mechanism to disease. Science 368, eaat5314 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8997189</ArticleId><ArticleId IdType="pubmed">32327570</ArticleId></ArticleIdList></Reference><Reference><Citation>Penkov S., et al. ., Integration of carbohydrate metabolism and redox state controls dauer larva formation in Caenorhabditis elegans. Nat. Commun. 6, 8060 (2015).</Citation><ArticleIdList><ArticleId IdType="pubmed">26290173</ArticleId></ArticleIdList></Reference><Reference><Citation>Burnstock G., An introduction to the roles of purinergic signalling in neurodegeneration, neuroprotection and neuroregeneration. Neuropharmacology 104, 4&#x2013;17 (2016).</Citation><ArticleIdList><ArticleId IdType="pubmed">26056033</ArticleId></ArticleIdList></Reference><Reference><Citation>Zolkipli-Cunningham Z., et al. ., Metabolic and behavioral features of acute hyperpurinergia and the maternal immune activation mouse model of autism spectrum disorder. PLoS One 16, e0248771 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7971557</ArticleId><ArticleId IdType="pubmed">33735311</ArticleId></ArticleIdList></Reference><Reference><Citation>Pei L., Wallace D. C., Mitochondrial etiology of neuropsychiatric disorders. Biol. Psychiatry 83, 722&#x2013;730 (2018).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5891364</ArticleId><ArticleId IdType="pubmed">29290371</ArticleId></ArticleIdList></Reference><Reference><Citation>Akaberi D., et al. ., Mitigation of the replication of SARS-CoV-2 by nitric oxide in vitro. Redox Biol. 37, 101734 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7505071</ArticleId><ArticleId IdType="pubmed">33007504</ArticleId></ArticleIdList></Reference><Reference><Citation>Lotz C., et al. ., Effects of inhaled nitric oxide in COVID-19-induced ARDS - Is it worthwhile? Acta Anaesthesiol. Scand. 65, 629&#x2013;632 (2021).</Citation><ArticleIdList><ArticleId IdType="pubmed">33296498</ArticleId></ArticleIdList></Reference><Reference><Citation>Fukuda S., et al. ., Ubiquinol-10 supplementation improves autonomic nervous function and cognitive function in chronic fatigue syndrome. Biofactors 42, 431&#x2013;440 (2016).</Citation><ArticleIdList><ArticleId IdType="pubmed">27125909</ArticleId></ArticleIdList></Reference><Reference><Citation>Castro-Marrero J., et al. ., Does oral coenzyme Q10 plus NADH supplementation improve fatigue and biochemical parameters in chronic fatigue syndrome? Antioxid. Redox Signal. 22, 679&#x2013;685 (2015).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4346380</ArticleId><ArticleId IdType="pubmed">25386668</ArticleId></ArticleIdList></Reference><Reference><Citation>Horowitz R. I., Freeman P. R., Bruzzese J., Efficacy of glutathione therapy in relieving dyspnea associated with COVID-19 pneumonia: A report of 2 cases. Respir. Med. Case Rep. 30, 101063 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7172740</ArticleId><ArticleId IdType="pubmed">32322478</ArticleId></ArticleIdList></Reference><Reference><Citation>Faller S., et al. ., Pre- and posttreatment with hydrogen sulfide prevents ventilator-induced lung injury by limiting inflammation and oxidation. PLoS One 12, e0176649 (2017).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5409137</ArticleId><ArticleId IdType="pubmed">28453540</ArticleId></ArticleIdList></Reference><Reference><Citation>Evgen&#x2019;ev M. B., Frenkel A., Possible application of H2S-producing compounds in therapy of coronavirus (COVID-19) infection and pneumonia. Cell Stress Chaperones 25, 713&#x2013;715 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7221330</ArticleId><ArticleId IdType="pubmed">32409956</ArticleId></ArticleIdList></Reference><Reference><Citation>Bazhanov N., Escaffre O., Freiberg A. N., Garofalo R. P., Casola A., Broad-range antiviral activity of hydrogen sulfide against highly pathogenic RNA viruses. Sci. Rep. 7, 41029 (2017).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5247713</ArticleId><ArticleId IdType="pubmed">28106111</ArticleId></ArticleIdList></Reference><Reference><Citation>Roblin X., Pofelski J., Zarski J. P., [Steatosis, chronic hepatitis virus C infection and homocysteine]. Gastroenterol. Clin. Biol. 31, 415&#x2013;420 (2007).</Citation><ArticleIdList><ArticleId IdType="pubmed">17483780</ArticleId></ArticleIdList></Reference><Reference><Citation>Deminice R., Silva T. C., de Oliveira V. H., Elevated homocysteine levels in human immunodeficiency virus-infected patients under antiretroviral therapy: A meta-analysis. World J. Virol. 4, 147&#x2013;155 (2015).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4419119</ArticleId><ArticleId IdType="pubmed">25964880</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao X., et al. ., Exogenous hydrogen sulfide inhibits neutrophils extracellular traps formation via the HMGB1/TLR4/p-38 MAPK/ROS axis in hyperhomocysteinemia rats. Biochem. Biophys. Res. Commun. 537, 7&#x2013;14 (2021).</Citation><ArticleIdList><ArticleId IdType="pubmed">33383564</ArticleId></ArticleIdList></Reference><Reference><Citation>Bourgonje A. R., et al. ., N-acetylcysteine and hydrogen sulfide in coronavirus disease 2019. Antioxid. Redox Signal., 10.1089/ars.2020.8247 (2021).</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/ars.2020.8247</ArticleId><ArticleId IdType="pubmed">33607929</ArticleId></ArticleIdList></Reference><Reference><Citation>Jin Z., et al. ., Structure of Mpro from SARS-CoV-2 and discovery of its inhibitors. Nature 582, 289&#x2013;293 (2020).</Citation><ArticleIdList><ArticleId IdType="pubmed">32272481</ArticleId></ArticleIdList></Reference><Reference><Citation>Sies H., Parnham M. J., Potential therapeutic use of ebselen for COVID-19 and other respiratory viral infections. Free Radic. Biol. Med. 156, 107&#x2013;112 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7319625</ArticleId><ArticleId IdType="pubmed">32598985</ArticleId></ArticleIdList></Reference><Reference><Citation>Barcelos I., Shadiack E., Ganetzky R. D., Falk M. J., Mitochondrial medicine therapies: Rationale, evidence, and dosing guidelines. Curr. Opin. Pediatr. 32, 707&#x2013;718 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7774245</ArticleId><ArticleId IdType="pubmed">33105273</ArticleId></ArticleIdList></Reference><Reference><Citation>Stanculescu D., Larsson L., Bergquist J., Hypothesis: Mechanisms that prevent recovery in prolonged ICU patients also underlie myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS). Front. Med. (Lausanne) 8, 628029 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7876311</ArticleId><ArticleId IdType="pubmed">33585528</ArticleId></ArticleIdList></Reference><Reference><Citation>Komaroff A. L., Lipkin W. I., Insights from myalgic encephalomyelitis/chronic fatigue syndrome may help unravel the pathogenesis of postacute COVID-19 syndrome. Trends Mol. Med., 10.1016/j.molmed.2021.06.002 (2021).</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molmed.2021.06.002</ArticleId><ArticleId IdType="pmc">PMC8180841</ArticleId><ArticleId IdType="pubmed">34175230</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang F., et al. ., The laboratory tests and host immunity of COVID-19 patients with different severity of illness. JCI Insight 5, 137799 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7259533</ArticleId><ArticleId IdType="pubmed">32324595</ArticleId></ArticleIdList></Reference><Reference><Citation>Kappert K., Jahi&#x107; A., Tauber R., Assessment of serum ferritin as a biomarker in COVID-19: Bystander or participant? Insights by comparison with other infectious and non-infectious diseases. Biomarkers 25, 616&#x2013;625 (2020).</Citation><ArticleIdList><ArticleId IdType="pubmed">32700561</ArticleId></ArticleIdList></Reference><Reference><Citation>Perricone C., et al. ., COVID-19 as part of the hyperferritinemic syndromes: The role of iron depletion therapy. Immunol. Res. 68, 213&#x2013;224 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7366458</ArticleId><ArticleId IdType="pubmed">32681497</ArticleId></ArticleIdList></Reference><Reference><Citation>Colafrancesco S., Alessandri C., Conti F., Priori R., COVID-19 gone bad: A new character in the spectrum of the hyperferritinemic syndrome? Autoimmun. Rev. 19, 102573 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7199723</ArticleId><ArticleId IdType="pubmed">32387470</ArticleId></ArticleIdList></Reference><Reference><Citation>Song J. W., et al. ., Omics-driven systems interrogation of metabolic dysregulation in COVID-19 pathogenesis. Cell Metab. 32, 188&#x2013;202.e5 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7311890</ArticleId><ArticleId IdType="pubmed">32610096</ArticleId></ArticleIdList></Reference><Reference><Citation>Shen B., et al. ., Proteomic and metabolomic characterization of COVID-19 patient sera. Cell 182, 59&#x2013;72.e15 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7254001</ArticleId><ArticleId IdType="pubmed">32492406</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang Z., et al. ., Predictors for imaging progression on chest CT from coronavirus disease 2019 (COVID-19) patients. Aging (Albany NY) 12, 6037&#x2013;6048 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7185104</ArticleId><ArticleId IdType="pubmed">32275643</ArticleId></ArticleIdList></Reference><Reference><Citation>Ponti G., Ruini C., Tomasi A., Homocysteine as a potential predictor of cardiovascular risk in patients with COVID-19. Med. Hypotheses 143, 109859 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7240252</ArticleId><ArticleId IdType="pubmed">32464494</ArticleId></ArticleIdList></Reference><Reference><Citation>Regland B., et al. ., Increased concentrations of homocysteine in the cerebrospinal fluid in patients with fibromyalgia and chronic fatigue syndrome. Scand. J. Rheumatol. 26, 301&#x2013;307 (1997).</Citation><ArticleIdList><ArticleId IdType="pubmed">9310111</ArticleId></ArticleIdList></Reference><Reference><Citation>Pietrangelo T., et al. ., Transcription profile analysis of vastus lateralis muscle from patients with chronic fatigue syndrome. Int. J. Immunopathol. Pharmacol. 22, 795&#x2013;807 (2009).</Citation><ArticleIdList><ArticleId IdType="pubmed">19822097</ArticleId></ArticleIdList></Reference><Reference><Citation>Henry B., et al. ., Lymphopenia and neutrophilia at admission predicts severity and mortality in patients with COVID-19: A meta-analysis. Acta Biomed. 91, e2020008 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7716963</ArticleId><ArticleId IdType="pubmed">32921706</ArticleId></ArticleIdList></Reference><Reference><Citation>Brenu E. W., et al. ., Role of adaptive and innate immune cells in chronic fatigue syndrome/myalgic encephalomyelitis. Int. Immunol. 26, 233&#x2013;242 (2014).</Citation><ArticleIdList><ArticleId IdType="pubmed">24343819</ArticleId></ArticleIdList></Reference><Reference><Citation>Thomas T., et al. ., COVID-19 infection alters kynurenine and fatty acid metabolism, correlating with IL-6 levels and renal status. JCI Insight 5, 140327 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7453907</ArticleId><ArticleId IdType="pubmed">32559180</ArticleId></ArticleIdList></Reference><Reference><Citation>Heer C. D., et al. ., Coronavirus infection and PARP expression dysregulate the NAD metabolome: An actionable component of innate immunity. J. Biol. Chem. 295, 17986&#x2013;17996 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7834058</ArticleId><ArticleId IdType="pubmed">33051211</ArticleId></ArticleIdList></Reference><Reference><Citation>Polonikov A., Endogenous deficiency of glutathione as the most likely cause of serious manifestations and death in COVID-19 patients. ACS Infect. Dis. 6, 1558&#x2013;1562 (2020).</Citation><ArticleIdList><ArticleId IdType="pubmed">32463221</ArticleId></ArticleIdList></Reference><Reference><Citation>Rhodes J. M., Subramanian S., Laird E., Griffin G., Kenny R. A., Perspective: Vitamin D deficiency and COVID-19 severity&#x2014;plausibly linked by latitude, ethnicity, impacts on cytokines, ACE2, and thrombosis. J. Intern. Med. 289, 97&#x2013;115 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7361294</ArticleId><ArticleId IdType="pubmed">32613681</ArticleId></ArticleIdList></Reference><Reference><Citation>Kennedy G., et al. ., Oxidative stress levels are raised in chronic fatigue syndrome and are associated with clinical symptoms. Free Radic. Biol. Med. 39, 584&#x2013;589 (2005).</Citation><ArticleIdList><ArticleId IdType="pubmed">16085177</ArticleId></ArticleIdList></Reference><Reference><Citation>Aoki T., Miyakoshi H., Usuda Y., Herberman R. B., Low NK syndrome and its relationship to chronic fatigue syndrome. Clin. Immunol. Immunopathol. 69, 253&#x2013;265 (1993).</Citation><ArticleIdList><ArticleId IdType="pubmed">8242898</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang J., Taylor E. W., Bennett K., Saad R., Rayman M. P., Association between regional selenium status and reported outcome of COVID-19 cases in China. Am. J. Clin. Nutr. 111, 1297&#x2013;1299 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7197590</ArticleId><ArticleId IdType="pubmed">32342979</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoffmann P. R., Berry M. J., The influence of selenium on immune responses. Mol. Nutr. Food Res. 52, 1273&#x2013;1280 (2008).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3723386</ArticleId><ArticleId IdType="pubmed">18384097</ArticleId></ArticleIdList></Reference><Reference><Citation>Steinbrenner H., Al-Quraishy S., Dkhil M. A., Wunderlich F., Sies H., Dietary selenium in adjuvant therapy of viral and bacterial infections. Adv. Nutr. 6, 73&#x2013;82 (2015).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4288282</ArticleId><ArticleId IdType="pubmed">25593145</ArticleId></ArticleIdList></Reference><Reference><Citation>Chiscano-Cam&#xf3;n L., Ruiz-Rodriguez J. C., Ruiz-Sanmartin A., Roca O., Ferrer R., Vitamin C levels in patients with SARS-CoV-2-associated acute respiratory distress syndrome. Crit. Care 24, 522 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7447967</ArticleId><ArticleId IdType="pubmed">32847620</ArticleId></ArticleIdList></Reference><Reference><Citation>Kennedy G., Khan F., Hill A., Underwood C., Belch J. J., Biochemical and vascular aspects of pediatric chronic fatigue syndrome. Arch. Pediatr. Adolesc. Med. 164, 817&#x2013;823 (2010).</Citation><ArticleIdList><ArticleId IdType="pubmed">20819963</ArticleId></ArticleIdList></Reference><Reference><Citation>Heer C. D., et al. ., Coronavirus infection and PARP expression dysregulate the NAD metabolome: An actionable component of innate immunity. J. Biol. Chem. 295, 17986&#x2013;17996 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7834058</ArticleId><ArticleId IdType="pubmed">33051211</ArticleId></ArticleIdList></Reference><Reference><Citation>Erol S. A., et al. ., Evaluation of maternal serum afamin and vitamin E levels in pregnant women with COVID-19 and its association with composite adverse perinatal outcomes. J. Med. Virol. 93, 2350&#x2013;2358 (2021).</Citation><ArticleIdList><ArticleId IdType="pubmed">33314206</ArticleId></ArticleIdList></Reference><Reference><Citation>Vecchiet J., et al. ., Relationship between musculoskeletal symptoms and blood markers of oxidative stress in patients with chronic fatigue syndrome. Neurosci. Lett. 335, 151&#x2013;154 (2003).</Citation><ArticleIdList><ArticleId IdType="pubmed">12531455</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>